We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Mobile Cardiac Telemetry Proves Cost-Effective

By HospiMedica International staff writers
Posted on 06 Jan 2014
Print article
A new study shows that monitoring patients with mobile cardiac telemetry (MCT) is better than using Event or Holter monitors.

Researcher at Bayser Consulting (Skokie, IL, USA) conducted a retrospective analysis of claims data from January 2007 to September 2011, pertaining to 200,000+ patients, of whom 14,000 used MCT only, 54,000 used an Event monitor only, and 163,000 used a Holter monitor only. The researchers used a pair-wise pre/post-test-control methodology to ensure that control patients were similar to test patients with regard to age, geographic location, type of cardiovascular diagnosis both in the inpatient and outpatient settings, and the cardiovascular drug class the patient used.

The results showed that the diagnostic yield of patients monitored with MCT is 61%, significantly higher than that of patients that use the Event monitor (23%), or the Holter monitor (24%). In addition, significantly more patients naive to antiarrhythmic drugs initiated therapy after monitoring with the MCT (61%), compared with 39% for patients that used the Event monitor, and 43% for patients that use the Holter monitor. Significant inpatient cardiovascular savings were found for patients that underwent ablation, coronary artery bypass graft (CABG), and valve septa procedures. The study was published on December 19, 2013, in Medical Devices: Evidence and Research.

“Given the superior outcome of MCT regarding both patient care and hospital savings, hospitals only stand to gain by enforcing protocols that favor the MCT system over the Event or the Holter monitor,” concluded study authors Jean-Patrick Tsang, PhD, MBA, and analyst Shunmugam Mohan.

The MCT is a small sensor and monitor developed by Cardionet (Pennsylvania, PA, USA) that patients wear daily. When a cardiac event occurs, the system instantaneously transmits the data to a center for analysis and response, which in turn sends a report along with graphs and trends to the patient's physician for diagnosis and therapy management.

Related Links:

Bayser Consulting
Cardionet


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Oxidized Zirconium Implant Material
OXINIUM

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.